Talniflumate (Genaera).

Article Details

Citation
Copy to clipboard

Knight D

Talniflumate (Genaera).

Curr Opin Investig Drugs. 2004 May;5(5):557-62.

PubMed ID
15202731 [ View in PubMed
]
Abstract

Talniflumate, an anti-inflammatory molecule that was originally developed by Laboratorios Bago, is currently being developed by Genaera as a mucoregulator for the treatment of cystic fibrosis, chronic obstructive pulmonary disease and asthma. Phase I trials with talniflumate had been completed by August 2001, and phase II trials were underway in Ireland for the treatment of cystic fibrosis.

DrugBank Data that Cites this Article

Drugs